Oncology

G. Paolino, M.W. Bekkenk, D. Didona, L. Eibenschutz, A.G. Richetta, C. Cantisani, G. Viti, A. Carbone, P. Buccini, P. De Simone, A. Ferrari, E. Scali, S. Calvieri, V. Silipo, E. Cigna, G.P. Viti, U. Bottoni
Free PDF Download

Eur Rev Med Pharmacol Sci 2016; 20 (5): 837-841

Diminished miR-613 expression as a novel prognostic biomarker for human ovarian cancer

X. Zhang, H. Zhang
Free PDF Download

Eur Rev Med Pharmacol Sci 2016; 20 (5): 830-836

Mutational status of EZH2 and CD79B hot spots in mature B-cell non-Hodgkin’s lymphomas: novel CD79B variations have been revealed

G.O. Cetin, I.C. Baris, V. Caner, B. Sarikepe, N. Sen Turk, E. Tepeli, S. Hacioglu, I. Sari, G. Bagci, A. Keskin
Free PDF Download

Eur Rev Med Pharmacol Sci 2016; 20 (5): 825-829

Involvement of miR-454 overexpression in the poor prognosis of hepatocellular carcinoma

L. Zhou, Y.-M. Qu, X.-M. Zhao, Z.-D. Yue
Free PDF Download

Eur Rev Med Pharmacol Sci 2016; 20 (5): 818-824

High-grade vaginal intraepithelial neoplasia and risk of progression to vaginal cancer: a multicentre study of the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV)

F. Sopracordevole, M. Barbero, N. Clemente, M.G. Fallani, P. Cattani, A. Agarossi, G. De Piero, A. Parin, A. Frega, F. Boselli, F. Mancioli, M. Buttignol, F. Currado, A. Pieralli, A. Ciavattini, Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV)
Free PDF Download

Eur Rev Med Pharmacol Sci 2016; 20 (5): 792-793

Comment on “Peripheral blood used in place of bone marrow aspirate for detection of translocation t(11;14) status during minimal residual disease monitoring is cost-effectiveness”

D. Valente A. Rainone
Free PDF Download

Eur Rev Med Pharmacol Sci 2016; 20 (5): 788-
DOI:

Preoperative neutrophil-to-lymphocyte ratio (NLR) may be predictive of pathologic stage in patients with bladder cancer larger than 3 cm

O. Celik, M. Akand, M.Z. Keskin, M. Yoldas, Y.O. Ilbey
Free PDF Download

Eur Rev Med Pharmacol Sci 2016; 20 (4): 642-651

Oncology

Mechanism of action of EBV, Bcl-2, p53, c-Myc and Rb in non-Hodgkin’s lymphoma

DTC chemotherapy regimen is associated with higher incidence of premature ovarian failure in women of reproductive age with breast cancer

MicroRNA-138 regulates chemoresistance in human non-small cell lung cancer via epithelial mesenchymal transition

Silencing of NUF2 inhibits proliferation of human osteosarcoma Saos-2 cells

Prostate cancer cell both microRNA aberrant expression-mediated autophagy and radiation therapy resistance with short cross-reference to epigenetic/genetic mechanism implications

Peripheral blood used in place of bone marrow aspirate for detection of translocation t(11;14) status during minimal residual disease monitoring is cost-effectiveness

Hypoxic markers in non-small cell lung cancer (NSCLC) – A review

Is the prognosis and course of acral melanoma related to site-specific clinicopathological features?

Diminished miR-613 expression as a novel prognostic biomarker for human ovarian cancer

Mutational status of EZH2 and CD79B hot spots in mature B-cell non-Hodgkin’s lymphomas: novel CD79B variations have been revealed

Involvement of miR-454 overexpression in the poor prognosis of hepatocellular carcinoma

High-grade vaginal intraepithelial neoplasia and risk of progression to vaginal cancer: a multicentre study of the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV)

Comment on “Peripheral blood used in place of bone marrow aspirate for detection of translocation t(11;14) status during minimal residual disease monitoring is cost-effectiveness”

Erratum

Identification of key genes involved in HER2-positive breast cancer

Study on the relationship between miR-520g and the development of breast cancer

Preoperative neutrophil-to-lymphocyte ratio (NLR) may be predictive of pathologic stage in patients with bladder cancer larger than 3 cm

Expression of CD27, CD28 and IL-17A in peripheral blood from patients with colorectal carcinoma

Laryngeal squamous cell carcinoma progression is associated with the NFκB signaling pathway regulated by IκB kinase β

MiR-874 inhibits cell growth and induces apoptosis by targeting STAT3 in human colorectal cancer cells